BFM
MBIO icon

Boothbay Fund Management’s Mustang Bio MBIO Stock Holding History

Boothbay Fund Management’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-29
Closed -$13K – 2447
2022
Q2 		$13K Sell
29
-35
-55% -$19.4K ﹤0.01% 2191
2022
Q1 		$49K Hold
64
– – ﹤0.01% 2184
2021
Q4 		$80K Hold
64
– – ﹤0.01% 1740
2021
Q3 		$130K Sell
64
-27
-30% -$58K ﹤0.01% 1737
2021
Q2 		$226K Hold
91
– – 0.01% 1450
2021
Q1 		$226K Hold
91
– – 0.01% 1313
2020
Q4 		$258K Sell
91
-128
-58% -$306K 0.01% 1009
2020
Q3 		$518K Buy
219
+147
+204% +$362K 0.03% 632
2020
Q2 		$172K Hold
72
– – 0.01% 814
2020
Q1 		$145K Sell
72
-1
-1% -$2.56K 0.01% 693
2019
Q4 		$225K Buy
+73
New +$167K 0.02% 671

Other funds holding MBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Boothbay Fund Management's MBIO Position: Q3 2022 in Review

Boothbay Fund Management sold out of Mustang Bio (MBIO) in Q3 2022, closing a stake of 29 shares — an estimated $13K sold.

Boothbay Fund Management first reported a position in MBIO in Q4 2019 and held it in 11 quarters. The position peaked at $518K in Q3 2020. 67 funds tracked by Wall St. Rank hold MBIO as of Q3 2022.

  • Boothbay Fund Management reported no remaining Mustang Bio position as of Q3 2022 after selling out during the quarter.
  • Boothbay Fund Management sold 29 Mustang Bio shares in Q3 2022, an estimated $13K.
  • Boothbay Fund Management first reported a position in Mustang Bio in Q4 2019 and held it in 11 quarters.
  • Boothbay Fund Management's Mustang Bio position peaked at $518K in Q3 2020.
  • 67 funds tracked by Wall St. Rank held Mustang Bio as of Q3 2022.

Based on Boothbay Fund Management's 13F filing for Q3 2022, filed 14 Nov 2022.